Works matching IS 23661070 AND DT 2024 AND VI 12 AND IP 2
Results: 16
Gene Therapy for Neurofibromatosis Type 2-Related Schwannomatosis: Recent Progress, Challenges, and Future Directions.
- Published in:
- Oncology & Therapy, 2024, v. 12, n. 2, p. 257, doi. 10.1007/s40487-024-00279-2
- By:
- Publication type:
- Article
Standardizing Integrated Oncology and Palliative Care Across Service Levels: Challenges in Demonstrating Effects in a Prospective Controlled Intervention Trial.
- Published in:
- Oncology & Therapy, 2024, v. 12, n. 2, p. 345, doi. 10.1007/s40487-024-00278-3
- By:
- Publication type:
- Article
Some Considerations on the Treatment of Laryngeal Verrucous Squamous Cell Carcinoma.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
Correction: Real-World Treatment Patterns and Survival Among Patients with Stage I–III, Non-Squamous, Non-Small Cell Lung Cancer Receiving Surgery as Primary Treatment.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Podcast on Emerging Treatment Options for Pediatric Patients with ALK-Positive Anaplastic Large Cell Lymphoma and Inflammatory Myofibroblastic Tumors.
- Published in:
- Oncology & Therapy, 2024, v. 12, n. 2, p. 247, doi. 10.1007/s40487-024-00275-6
- By:
- Publication type:
- Article
Is There any Relationship Between the Repeated Complications of Sickle Cell Disease and the Potential Development of Acute Leukemia?
- Published in:
- Oncology & Therapy, 2024, v. 12, n. 2, p. 233, doi. 10.1007/s40487-024-00274-7
- By:
- Publication type:
- Article
Optimizing Real-World Outcomes in High-Risk Relapsed/Refractory (r/r) FL with CAR-T Cell Therapy: A Vodcast and Case Example.
- Published in:
- Oncology & Therapy, 2024, v. 12, n. 2, p. 217, doi. 10.1007/s40487-024-00269-4
- By:
- Publication type:
- Article
Some Considerations on Laryngeal Neuroendocrine Neoplasms.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
Identification of a Patient Suitable for CAR-T Cell Therapy in the Outpatient Setting: A Vodcast and Case Example.
- Published in:
- Oncology & Therapy, 2024, v. 12, n. 2, p. 239, doi. 10.1007/s40487-024-00272-9
- By:
- Publication type:
- Article
Unraveling the Dietary Puzzle: Exploring the Influence of Diet, Nutraceuticals, and Supplements on Bladder Cancer Risk, Outcomes, and Immunotherapy Efficacy: Insights from the BLOSSOM Study and Beyond.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
The Importance of Biomarker Testing in the Treatment of Advanced Non-Small Cell Lung Cancer: A Podcast.
- Published in:
- Oncology & Therapy, 2024, v. 12, n. 2, p. 223, doi. 10.1007/s40487-024-00271-w
- By:
- Publication type:
- Article
The Impact of Prior Single-Gene Testing on Comprehensive Genomic Profiling Results for Patients with Non-Small Cell Lung Cancer.
- Published in:
- Oncology & Therapy, 2024, v. 12, n. 2, p. 329, doi. 10.1007/s40487-024-00270-x
- By:
- Publication type:
- Article
Real-World Treatment Patterns and Survival Among Patients with Stage I–III, Non-Squamous, Non-Small Cell Lung Cancer Receiving Surgery as Primary Treatment.
- Published in:
- Oncology & Therapy, 2024, v. 12, n. 2, p. 311, doi. 10.1007/s40487-024-00268-5
- By:
- Publication type:
- Article
A Podcast on Pre- or Perioperative Chemoimmunotherapy for Stage III Non-Small Cell Lung Cancer: Shared Agreement from the Thoracic Surgeon and Oncologist Perspectives.
- Published in:
- Oncology & Therapy, 2024, v. 12, n. 2, p. 207, doi. 10.1007/s40487-024-00267-6
- By:
- Publication type:
- Article
Epidemiology and Real-World Treatment of Incident Diffuse Large B-cell Lymphoma (DLBCL): A German Claims Data Analysis.
- Published in:
- Oncology & Therapy, 2024, v. 12, n. 2, p. 293, doi. 10.1007/s40487-024-00265-8
- By:
- Publication type:
- Article
Estimating Public Economic Gains from Early Breast Cancer and Curative Treatment: A Case Study in Human Epidermal Growth Factor Receptor (HER-2) Positive Targeted Therapies.
- Published in:
- Oncology & Therapy, 2024, v. 12, n. 2, p. 277, doi. 10.1007/s40487-024-00264-9
- By:
- Publication type:
- Article